| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.90e-06 | 14 | 135 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.44e-05 | 46 | 135 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.78e-05 | 129 | 135 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.59e-05 | 151 | 135 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 1.36e-04 | 3 | 135 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.71e-04 | 19 | 135 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 4.48e-04 | 5 | 135 | 2 | GO:0000298 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.48e-04 | 5 | 135 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 4.48e-04 | 5 | 135 | 2 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 4.48e-04 | 5 | 135 | 2 | GO:0008486 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 6.69e-04 | 6 | 135 | 2 | GO:0034432 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 7.01e-04 | 26 | 135 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 9.32e-04 | 7 | 135 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.25e-03 | 118 | 135 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | phospholipid binding | MYO1G MYO10 PCLO ATG2B SNX16 PIK3C2B GLE1 ACAP2 MCTP2 UNC13A ARAP2 | 1.26e-03 | 548 | 135 | 11 | GO:0005543 |
| GeneOntologyMolecularFunction | spectrin binding | 1.55e-03 | 34 | 135 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 1.58e-03 | 9 | 135 | 2 | GO:0016308 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 1.25e-05 | 23 | 131 | 4 | GO:0061577 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | KIF13B ANK3 SZT2 MYO10 DACT2 LAMB1 ARHGEF18 SPAG9 PIP5K1C GRHL2 BRWD3 CHRNB2 RNF6 ATXN2 GLI2 GLI3 EPHA2 UNC13A EPHA5 EPHA8 | 6.45e-05 | 1194 | 131 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 7.24e-05 | 68 | 131 | 5 | GO:0007528 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 1.20e-04 | 3 | 131 | 2 | GO:0021775 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 1.20e-04 | 3 | 131 | 2 | GO:0021776 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord patterning | 1.20e-04 | 3 | 131 | 2 | GO:0021910 | |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 1.20e-04 | 3 | 131 | 2 | GO:0098912 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 7.91e-07 | 12 | 135 | 4 | GO:1990454 | |
| GeneOntologyCellularComponent | nuclear body | CENPC AHCTF1 CMYA5 KLHL20 RBM25 UBN1 RNF6 RBM27 GLI2 GLI3 ZNF451 WBP4 LPXN CHFR PIP5K1A HECTD1 SON | 7.35e-05 | 903 | 135 | 17 | GO:0016604 |
| GeneOntologyCellularComponent | calcium channel complex | 1.10e-04 | 73 | 135 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 1.60e-04 | 79 | 135 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.20e-04 | 46 | 135 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 2.46e-04 | 4 | 135 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | nuclear speck | 4.98e-04 | 431 | 135 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.62e-04 | 360 | 135 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | PML body | 1.32e-03 | 125 | 135 | 5 | GO:0016605 | |
| Domain | VDCC_L_bsu | 1.40e-06 | 4 | 133 | 3 | IPR000584 | |
| Domain | VGCC_beta4Aa_N | 1.40e-06 | 4 | 133 | 3 | PF12052 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.21e-04 | 14 | 133 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.21e-04 | 14 | 133 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.21e-04 | 14 | 133 | 3 | IPR001426 | |
| Domain | EphA2_TM | 1.21e-04 | 14 | 133 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.21e-04 | 14 | 133 | 3 | IPR001090 | |
| Domain | Eph_TM | 1.21e-04 | 14 | 133 | 3 | IPR027936 | |
| Domain | EPH_lbd | 1.21e-04 | 14 | 133 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 1.21e-04 | 14 | 133 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.21e-04 | 14 | 133 | 3 | IPR016257 | |
| Domain | EPH_LBD | 1.21e-04 | 14 | 133 | 3 | PS51550 | |
| Domain | PWI | 4.96e-04 | 5 | 133 | 2 | PF01480 | |
| Domain | - | 4.96e-04 | 5 | 133 | 2 | 1.20.1390.10 | |
| Domain | PWI_dom | 4.96e-04 | 5 | 133 | 2 | IPR002483 | |
| Domain | Galactose-bd-like | 5.61e-04 | 94 | 133 | 5 | IPR008979 | |
| Domain | Ephrin_rec_like | 7.24e-04 | 25 | 133 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.24e-04 | 25 | 133 | 3 | IPR011641 | |
| Domain | Kinesin_assoc | 7.41e-04 | 6 | 133 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 7.41e-04 | 6 | 133 | 2 | IPR032405 | |
| Domain | Guanylate_kin | 8.14e-04 | 26 | 133 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 8.14e-04 | 26 | 133 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 8.14e-04 | 26 | 133 | 3 | IPR008144 | |
| Domain | GuKc | 8.14e-04 | 26 | 133 | 3 | SM00072 | |
| Domain | FHA | 1.02e-03 | 28 | 133 | 3 | SM00240 | |
| Domain | PInositol-4-P-5-kinase | 1.03e-03 | 7 | 133 | 2 | IPR023610 | |
| Domain | PIPKc | 1.37e-03 | 8 | 133 | 2 | SM00330 | |
| Domain | - | 1.37e-03 | 8 | 133 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 1.37e-03 | 8 | 133 | 2 | PF01504 | |
| Domain | PIPK | 1.37e-03 | 8 | 133 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 1.37e-03 | 8 | 133 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 1.37e-03 | 8 | 133 | 2 | IPR027483 | |
| Domain | - | 1.37e-03 | 8 | 133 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 1.37e-03 | 8 | 133 | 2 | IPR002498 | |
| Domain | FHA_DOMAIN | 1.37e-03 | 31 | 133 | 3 | PS50006 | |
| Domain | FHA | 1.37e-03 | 31 | 133 | 3 | PF00498 | |
| Domain | SAM_1 | 1.41e-03 | 68 | 133 | 4 | PF00536 | |
| Domain | - | 1.83e-03 | 73 | 133 | 4 | 2.60.120.260 | |
| Domain | - | 2.12e-03 | 36 | 133 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 2.12e-03 | 36 | 133 | 3 | IPR000253 | |
| Domain | C2 | 2.47e-03 | 131 | 133 | 5 | PF00168 | |
| Domain | EGF-like_CS | 2.68e-03 | 261 | 133 | 7 | IPR013032 | |
| Domain | EGF_2 | 2.92e-03 | 265 | 133 | 7 | PS01186 | |
| Domain | C2 | 3.00e-03 | 137 | 133 | 5 | SM00239 | |
| Domain | Znf_C2H2_matrin | 3.17e-03 | 12 | 133 | 2 | IPR000690 | |
| Domain | C2 | 3.49e-03 | 142 | 133 | 5 | PS50004 | |
| Domain | SAM | 3.61e-03 | 88 | 133 | 4 | SM00454 | |
| Domain | PH | 3.80e-03 | 278 | 133 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 3.88e-03 | 279 | 133 | 7 | PS50003 | |
| Domain | PH_domain | 3.95e-03 | 280 | 133 | 7 | IPR001849 | |
| Domain | - | 4.17e-03 | 148 | 133 | 5 | 2.60.40.150 | |
| Domain | - | 4.33e-03 | 14 | 133 | 2 | 3.90.890.10 | |
| Domain | SAM_DOMAIN | 4.75e-03 | 95 | 133 | 4 | PS50105 | |
| Domain | SAM | 5.11e-03 | 97 | 133 | 4 | IPR001660 | |
| Domain | Post-SET_dom | 5.66e-03 | 16 | 133 | 2 | IPR003616 | |
| Domain | PostSET | 5.66e-03 | 16 | 133 | 2 | SM00508 | |
| Domain | SIAH-type | 5.66e-03 | 16 | 133 | 2 | IPR013323 | |
| Domain | POST_SET | 5.66e-03 | 16 | 133 | 2 | PS50868 | |
| Domain | SMAD_FHA_domain | 6.05e-03 | 52 | 133 | 3 | IPR008984 | |
| Domain | fn3 | 6.09e-03 | 162 | 133 | 5 | PF00041 | |
| Domain | C2_dom | 6.41e-03 | 164 | 133 | 5 | IPR000008 | |
| Domain | - | 6.98e-03 | 106 | 133 | 4 | 1.10.150.50 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 8.18e-06 | 21 | 89 | 4 | M47950 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.33e-05 | 8 | 89 | 3 | MM15197 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.70e-05 | 25 | 89 | 4 | M47948 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.87e-05 | 11 | 89 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.87e-05 | 11 | 89 | 3 | M26913 | |
| Pathway | PID_ARF6_PATHWAY | 6.69e-05 | 35 | 89 | 4 | M86 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 8.42e-05 | 14 | 89 | 3 | MM15198 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 1.05e-04 | 15 | 89 | 3 | M27456 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.38e-04 | 42 | 89 | 4 | M7169 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 2.98e-04 | 21 | 89 | 3 | M47949 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.66e-04 | 63 | 89 | 4 | M11187 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 7.11e-04 | 28 | 89 | 3 | M10679 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 7.89e-04 | 29 | 89 | 3 | M27309 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 8.11e-04 | 7 | 89 | 2 | M27501 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | CACNA1C CACNB1 CACNB2 CACNB3 ANK3 MYO10 LAMB1 PIP5K1C EPHA2 EPHA5 EPHA8 | 9.63e-04 | 575 | 89 | 11 | M29853 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.06e-03 | 32 | 89 | 3 | M27455 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.22e-03 | 74 | 89 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.22e-03 | 74 | 89 | 4 | M16376 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.26e-03 | 34 | 89 | 3 | M177 | |
| Pubmed | Calmodulin-dependent gating of Ca(v)1.2 calcium channels in the absence of Ca(v)beta subunits. | 2.24e-10 | 4 | 136 | 4 | 18535142 | |
| Pubmed | 1.12e-09 | 5 | 136 | 4 | 19723630 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TRAF7 KIF13B ZNF507 TACC2 SMARCAD1 ZNF318 FAM83B SETDB1 SETD2 UBN1 PIK3C2B ZNF451 NAV1 CRYBG3 CPSF7 RPAP2 | 1.47e-09 | 588 | 136 | 16 | 38580884 |
| Pubmed | Mice with cardiac-specific sequestration of the beta-subunit of the L-type calcium channel. | 5.85e-08 | 3 | 136 | 3 | 12054671 | |
| Pubmed | 7.23e-08 | 11 | 136 | 4 | 18809727 | ||
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 10494839 | ||
| Pubmed | 2.33e-07 | 4 | 136 | 3 | 19996312 | ||
| Pubmed | 2.95e-07 | 15 | 136 | 4 | 20188150 | ||
| Pubmed | 2.95e-07 | 15 | 136 | 4 | 24453333 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 4.00e-07 | 171 | 136 | 8 | 20201926 | |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 16787652 | ||
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 11980879 | ||
| Pubmed | KIF13B VPS18 ARHGEF18 SPAG9 SETD2 FAT2 TRPM3 POP1 FAM169A HECTD1 KIF1C PDZRN4 | 5.97e-07 | 493 | 136 | 12 | 15368895 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DLGAP2 ANK3 ARHGEF18 SMARCAD1 PIP5K1C NBPF20 UBN1 ATXN2 GLI2 SON FAM110B | 1.11e-06 | 430 | 136 | 11 | 35044719 |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 10328888 | ||
| Pubmed | VPS18 CENPC ATG2B SPAG9 SPICE1 UBN1 RBM27 FAM169A NAV1 PIP5K1A ACAP2 CPSF7 RPAP2 | 1.64e-06 | 645 | 136 | 13 | 25281560 | |
| Pubmed | TRAF7 AHCTF1 LAMB1 HIC2 SMARCAD1 ZNF318 BRWD3 SETDB1 SETD2 RBM25 GLI3 SMARCA2 CRYBG3 AGTPBP1 ARAP2 SON RPAP2 | 1.83e-06 | 1116 | 136 | 17 | 31753913 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | FLG AHCYL1 SZT2 CA14 UBE2U KLHL20 SETDB1 RHEX IARS2 PIK3C2B DNAI4 PIP5K1A SLC45A1 SLFNL1 EPHA8 RPAP2 | 2.98e-06 | 1031 | 136 | 16 | 16710414 |
| Pubmed | Bridging expressed sequence alignments through targeted cDNA sequencing. | 3.23e-06 | 8 | 136 | 3 | 15028280 | |
| Pubmed | 3.75e-06 | 105 | 136 | 6 | 9628581 | ||
| Pubmed | MYO10 SMARCAD1 SPATA2 PIP5K1C SETDB1 ZNF451 NAV1 AGTPBP1 ARAP2 SON | 4.95e-06 | 407 | 136 | 10 | 12693553 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C CACNB2 CACNB3 POLR1A ANK3 ARHGEF18 GRHL2 BRWD3 CFAP20DC TRNT1 ATXN2 CLMN GLI2 SMARCA2 NAV1 PIP5K1A HECTD1 MCTP2 RPAP2 | 5.75e-06 | 1489 | 136 | 19 | 28611215 |
| Pubmed | 5.81e-06 | 65 | 136 | 5 | 23453885 | ||
| Pubmed | KIF13B DLGAP2 CACNB1 CACNB2 ANK3 CYTH1 ARHGEF18 ZNF318 CYRIB SPICE1 ATXN2 NAV1 PLCL1 JAKMIP1 UNC13A | 5.94e-06 | 963 | 136 | 15 | 28671696 | |
| Pubmed | POLR1A ARHGEF18 SETDB1 SETD2 IARS2 CLMN GLE1 ZNF451 WBP4 NAV1 HECTD1 AGTPBP1 RPAP2 | 6.55e-06 | 733 | 136 | 13 | 34672954 | |
| Pubmed | 6.88e-06 | 10 | 136 | 3 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 6.88e-06 | 10 | 136 | 3 | 16547242 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.50e-06 | 184 | 136 | 7 | 32908313 | |
| Pubmed | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. | 9.43e-06 | 11 | 136 | 3 | 24550361 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 9.43e-06 | 11 | 136 | 3 | 20351715 | |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 15517401 | ||
| Pubmed | 9.82e-06 | 263 | 136 | 8 | 34702444 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.25e-05 | 358 | 136 | 9 | 32460013 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 1.25e-05 | 12 | 136 | 3 | 19247962 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.34e-05 | 37 | 136 | 4 | 25798587 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.49e-05 | 38 | 136 | 4 | 30786075 | |
| Pubmed | Effects of CACNA1C and ANK3 on cognitive function in patients with bipolar disorder. | 1.52e-05 | 2 | 136 | 2 | 38657895 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 21676128 | ||
| Pubmed | No association between bipolar disorder risk polymorphisms in ANK3 and CACNA1C and common migraine. | 1.52e-05 | 2 | 136 | 2 | 21395576 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22647524 | ||
| Pubmed | PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. | 1.52e-05 | 2 | 136 | 2 | 18073347 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12682053 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10465427 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34072954 | ||
| Pubmed | Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia. | 1.52e-05 | 2 | 136 | 2 | 23442119 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24108394 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17283082 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32376619 | ||
| Pubmed | Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis. | 1.52e-05 | 2 | 136 | 2 | 26227746 | |
| Pubmed | Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. | 1.52e-05 | 2 | 136 | 2 | 8494331 | |
| Pubmed | Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. | 1.52e-05 | 2 | 136 | 2 | 19153220 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10693670 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 10066897 | ||
| Pubmed | Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression. | 1.52e-05 | 2 | 136 | 2 | 20636642 | |
| Pubmed | Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner. | 1.52e-05 | 2 | 136 | 2 | 23300084 | |
| Pubmed | Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation. | 1.52e-05 | 2 | 136 | 2 | 27814383 | |
| Pubmed | Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data. | 1.52e-05 | 2 | 136 | 2 | 24716743 | |
| Pubmed | Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. | 1.52e-05 | 2 | 136 | 2 | 29967343 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20154143 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 14762176 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15339916 | ||
| Pubmed | PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. | 1.52e-05 | 2 | 136 | 2 | 19889969 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12920136 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 14674701 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24643163 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 33658391 | ||
| Pubmed | A study on etiology of incontinence in double knockout mouse model. | 1.52e-05 | 2 | 136 | 2 | 36272934 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 1.63e-05 | 13 | 136 | 3 | 17039519 | |
| Pubmed | 1.63e-05 | 13 | 136 | 3 | 12528186 | ||
| Pubmed | FLG FNDC3B CARMIL3 PROCA1 SNX16 CMYA5 GRHL2 PHF20L1 ZNF451 CEP126 MMP8 IL17RD | 1.73e-05 | 686 | 136 | 12 | 29987050 | |
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 19783738 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 26941654 | ||
| Pubmed | AHCYL1 ANK3 CENPC AHCTF1 LAMB1 SMARCAD1 DMXL1 SPICE1 FAM83B IARS2 PDE12 CLMN EPHA2 ZNF451 POP1 PIP5K1A CRYBG3 AGTPBP1 | 2.09e-05 | 1487 | 136 | 18 | 33957083 | |
| Pubmed | RC3H2 AHCYL1 DUSP2 PIP5K1C KLHL20 DMXL1 TRPM3 SMARCA2 PIP5K1A PLCL1 MMP8 UAP1L1 | 3.17e-05 | 730 | 136 | 12 | 34857952 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 3.82e-05 | 17 | 136 | 3 | 12217323 | |
| Pubmed | FLG AHCYL1 ZNF507 HIC2 SPAG9 ZNF318 SPATA2 SETDB1 RBM25 UBN1 ATXN2 RBM27 GLI2 GLI3 ZNF451 SMARCA2 CPSF7 | 4.49e-05 | 1429 | 136 | 17 | 35140242 | |
| Pubmed | Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. | 4.54e-05 | 3 | 136 | 2 | 11172440 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26010061 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 20817017 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25107449 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 8387379 | ||
| Pubmed | Positive regulation of Hedgehog signaling via phosphorylation of GLI2/GLI3 by DYRK2 kinase. | 4.54e-05 | 3 | 136 | 2 | 38968120 | |
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 4.54e-05 | 3 | 136 | 2 | 16571352 | |
| Pubmed | Resequencing three candidate genes for major depressive disorder in a Dutch cohort. | 4.54e-05 | 3 | 136 | 2 | 24278217 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 19106618 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 14681219 | ||
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 4.54e-05 | 3 | 136 | 2 | 22178118 | |
| Pubmed | Myosin X Interaction with KIF13B, a Crucial Pathway for Netrin-1-Induced Axonal Development. | 4.54e-05 | 3 | 136 | 2 | 33097641 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 16737551 | ||
| Pubmed | CLIC1 recruits PIP5K1A/C to induce cell-matrix adhesions for tumor metastasis. | 4.54e-05 | 3 | 136 | 2 | 33079727 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 8152808 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 17224476 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 19955409 | ||
| Pubmed | MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. | 4.54e-05 | 3 | 136 | 2 | 21098446 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 27582484 | ||
| Pubmed | Requirement of the Ca2+ channel β2 subunit for sympathetic PKA phosphorylation. | 4.54e-05 | 3 | 136 | 2 | 33602505 | |
| Pubmed | Sonic hedgehog through Gli2 and Gli3 is required for the proper development of placental labyrinth. | 4.54e-05 | 3 | 136 | 2 | 25695606 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 31462068 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 29455378 | ||
| Pubmed | Structural basis of the alpha1-beta subunit interaction of voltage-gated Ca2+ channels. | 4.54e-05 | 3 | 136 | 2 | 15170217 | |
| Interaction | CACNB2 interactions | 3.82e-07 | 23 | 135 | 5 | int:CACNB2 | |
| Interaction | SRGAP2 interactions | 7.35e-06 | 197 | 135 | 9 | int:SRGAP2 | |
| Cytoband | 6p12.1 | 1.30e-04 | 33 | 136 | 3 | 6p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.14e-04 | 404 | 136 | 7 | chr1q21 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.99e-06 | 26 | 93 | 4 | 253 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.60e-05 | 14 | 93 | 3 | 1095 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.14e-04 | 26 | 93 | 3 | 904 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.44e-04 | 181 | 93 | 6 | 694 | |
| GeneFamily | Sterile alpha motif domain containing | 1.10e-03 | 88 | 93 | 4 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 1.42e-03 | 160 | 93 | 5 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.23e-03 | 206 | 93 | 5 | 682 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPC MYO10 CYTH1 AHCTF1 SPAG9 KLHL20 SETDB1 SETD2 ATXN2 ZNF451 WBP4 FAM169A SMARCA2 PIP5K1A CRYBG3 ACAP2 ARAP2 SON | 4.91e-07 | 856 | 136 | 18 | M4500 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | CACNA1C CACNB3 ANK3 CARMIL3 PCLO TACC2 ATXN2 SMARCA2 NAV1 CEP126 AGTPBP1 FAM110B EPHA5 | 1.67e-06 | 488 | 136 | 13 | M39104 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | CENPC AHCTF1 ZNF507 HIC2 SPAG9 METTL14 PDE12 UBN1 PHF20L1 RBM27 ZNF451 FAM169A PLCL1 MCTP2 SON | 2.65e-06 | 680 | 136 | 15 | M41089 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN | 9.84e-06 | 199 | 136 | 8 | M3738 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 3.78e-05 | 240 | 136 | 8 | M39236 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPC MYO10 AHCTF1 SMARCAD1 SNX16 DMXL1 PHF20L1 RBM27 WBP4 SMARCA2 HECTD1 AGTPBP1 SON | 3.89e-05 | 656 | 136 | 13 | M18979 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 4.25e-05 | 244 | 136 | 8 | M40312 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.44e-05 | 180 | 136 | 7 | M8239 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 8.36e-05 | 199 | 136 | 7 | M6964 | |
| Coexpression | ROVERSI_GLIOMA_LOH_REGIONS | 8.76e-05 | 45 | 136 | 4 | M6712 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP | AHCTF1 ZNF507 KLHL20 SETDB1 IARS2 ZNF451 PIP5K1A ZNF264 IMPG2 | 9.02e-05 | 349 | 136 | 9 | M283 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 9.65e-05 | 141 | 136 | 6 | M39235 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-07 | 188 | 136 | 8 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.29e-07 | 190 | 136 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.29e-07 | 190 | 136 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.35e-07 | 191 | 136 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.58e-07 | 195 | 136 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-07 | 198 | 136 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.85e-07 | 199 | 136 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-07 | 200 | 136 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 176 | 136 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-06 | 178 | 136 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 181 | 136 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.54e-06 | 183 | 136 | 7 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.60e-06 | 184 | 136 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.66e-06 | 185 | 136 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 189 | 136 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.91e-06 | 189 | 136 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.91e-06 | 189 | 136 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 189 | 136 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 189 | 136 | 7 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.91e-06 | 189 | 136 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.98e-06 | 190 | 136 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.98e-06 | 190 | 136 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.07e-06 | 122 | 136 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.12e-06 | 192 | 136 | 7 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.12e-06 | 192 | 136 | 7 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 192 | 136 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.19e-06 | 193 | 136 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-06 | 193 | 136 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 193 | 136 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-06 | 193 | 136 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.19e-06 | 193 | 136 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-06 | 194 | 136 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.27e-06 | 194 | 136 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 194 | 136 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-06 | 194 | 136 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-06 | 194 | 136 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.35e-06 | 195 | 136 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-06 | 195 | 136 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-06 | 196 | 136 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.51e-06 | 197 | 136 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.60e-06 | 198 | 136 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.60e-06 | 198 | 136 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.78e-06 | 200 | 136 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.94e-06 | 154 | 136 | 6 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 165 | 136 | 6 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 165 | 136 | 6 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 165 | 136 | 6 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.22e-05 | 166 | 136 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-05 | 167 | 136 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-05 | 173 | 136 | 6 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.64e-05 | 175 | 136 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 177 | 136 | 6 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-05 | 178 | 136 | 6 | 3d120458a0a56097532ebfa5fc6f77b52af2af2a | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.87e-05 | 179 | 136 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 180 | 136 | 6 | 14ca8875af7cceead88fec147a4c0ef4d5a41f26 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 136 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 181 | 136 | 6 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.12e-05 | 183 | 136 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 183 | 136 | 6 | 20f7b6ec2462032eda957a893ca76d5a5a01333d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 183 | 136 | 6 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 184 | 136 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 185 | 136 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 136 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 186 | 136 | 6 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.32e-05 | 186 | 136 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-05 | 186 | 136 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.39e-05 | 187 | 136 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 187 | 136 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 187 | 136 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.39e-05 | 187 | 136 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.46e-05 | 188 | 136 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 188 | 136 | 6 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.46e-05 | 188 | 136 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 136 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 188 | 136 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.54e-05 | 189 | 136 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 136 | 6 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 189 | 136 | 6 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 189 | 136 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-05 | 190 | 136 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-05 | 190 | 136 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-05 | 190 | 136 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 191 | 136 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 191 | 136 | 6 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-05 | 191 | 136 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.77e-05 | 192 | 136 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| Drug | Nimodipine | 1.50e-07 | 9 | 136 | 4 | DB00393 | |
| Drug | Mibefradil | 3.89e-07 | 11 | 136 | 4 | DB01388 | |
| Drug | Verapamil | 2.10e-06 | 16 | 136 | 4 | DB00661 | |
| Drug | Magnesium Sulfate | 4.12e-06 | 6 | 136 | 3 | DB00653 | |
| Drug | adriamycinone | 4.12e-06 | 6 | 136 | 3 | CID000072401 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.78e-05 | 188 | 136 | 8 | 6735_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.00e-05 | 191 | 136 | 8 | 4303_DN | |
| Drug | Cinildipine | 2.11e-05 | 56 | 136 | 5 | CID000002752 | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.15e-05 | 193 | 136 | 8 | 3989_UP | |
| Drug | myo-inositol | CACNA1C CACNB1 CACNB2 CACNB3 POLR1A CYTH1 DUSP2 CAT SPAG9 PIP5K1C GRM7 NUDT4 PIK3C2B GLE1 PLCL1 ALOX15B | 2.82e-05 | 811 | 136 | 16 | CID000000892 |
| Drug | IAA-94 | 3.21e-05 | 61 | 136 | 5 | CID000003667 | |
| Disease | Major Depressive Disorder | 1.37e-05 | 243 | 131 | 8 | C1269683 | |
| Disease | Unipolar Depression | 2.16e-05 | 259 | 131 | 8 | C0041696 | |
| Disease | Anhedonia | 1.62e-04 | 24 | 131 | 3 | C0178417 | |
| Disease | Partial Fetal Alcohol Syndrome | 1.94e-04 | 5 | 131 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 1.94e-04 | 5 | 131 | 2 | C0814154 | |
| Disease | response to silica exposure, pneumoconiosis | 1.94e-04 | 5 | 131 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1C FNDC3B CACNB2 AHCYL1 ANK3 GSX2 BMP5 TRPM3 ATXN2 NAV1 PDE11A | 2.06e-04 | 670 | 131 | 11 | EFO_0006335, EFO_0006336 |
| Disease | cardiovascular disease | 2.12e-04 | 457 | 131 | 9 | EFO_0000319 | |
| Disease | Alcohol Related Birth Defect | 2.90e-04 | 6 | 131 | 2 | C3146244 | |
| Disease | Colorectal Carcinoma | CACNB1 CACNB2 VPS18 EFS MCF2L2 GLI3 JAKMIP1 MS4A5 AGTPBP1 FAM110B PDZRN4 | 3.07e-04 | 702 | 131 | 11 | C0009402 |
| Disease | grapefruit juice consumption measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0010094 | |
| Disease | Brugada syndrome | 5.38e-04 | 8 | 131 | 2 | cv:C1142166 | |
| Disease | Schizophrenia | CACNA1C DLGAP2 CACNB2 ANK3 CMYA5 GRM7 CHRNB2 SETDB1 ATXN2 SMARCA2 NAV1 MCTP2 | 5.86e-04 | 883 | 131 | 12 | C0036341 |
| Disease | Ischemic stroke | 6.30e-04 | 324 | 131 | 7 | HP_0002140 | |
| Disease | unipolar depression, bipolar disorder | 6.75e-04 | 156 | 131 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | pseudoxanthoma elasticum (is_implicated_in) | 6.90e-04 | 9 | 131 | 2 | DOID:2738 (is_implicated_in) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 6.90e-04 | 9 | 131 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 6.90e-04 | 9 | 131 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | dentate gyrus volume measurement | 6.95e-04 | 39 | 131 | 3 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 8.06e-04 | 41 | 131 | 3 | EFO_0009396 | |
| Disease | Adenoid Cystic Carcinoma | 1.05e-03 | 100 | 131 | 4 | C0010606 | |
| Disease | Shortened QT interval | 1.05e-03 | 11 | 131 | 2 | C0151879 | |
| Disease | serum metabolite measurement | CACNB2 PDE3A PKD1L1 LAMB1 CAT GRM7 GRHL2 CFAP20DC CLMN CHFR PLCL1 PDZRN4 | 1.05e-03 | 945 | 131 | 12 | EFO_0005653 |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.09e-03 | 101 | 131 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Autistic Disorder | 1.12e-03 | 261 | 131 | 6 | C0004352 | |
| Disease | Antihypertensive use measurement | 1.22e-03 | 265 | 131 | 6 | EFO_0009927 | |
| Disease | Secondary Open Angle Glaucoma | 1.25e-03 | 12 | 131 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 1.25e-03 | 12 | 131 | 2 | C0017612 | |
| Disease | age at menarche | FNDC3B DLGAP2 MYO10 SMARCAD1 FAM83B TRPM3 SMARCA2 PLCL1 EPHA5 | 1.38e-03 | 594 | 131 | 9 | EFO_0004703 |
| Disease | Malignant mesothelioma | 1.44e-03 | 109 | 131 | 4 | C0345967 | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.48e-03 | 13 | 131 | 2 | C2985290 | |
| Disease | Glaucoma, Primary Open Angle | 1.48e-03 | 13 | 131 | 2 | C0339573 | |
| Disease | inositol measurement | 1.72e-03 | 14 | 131 | 2 | EFO_0010504 | |
| Disease | Amyotrophic Lateral Sclerosis | 2.21e-03 | 58 | 131 | 3 | C0002736 | |
| Disease | Schizoaffective disorder-bipolar type | 2.25e-03 | 16 | 131 | 2 | EFO_0009965 | |
| Disease | hemoglobin A1 measurement | 2.30e-03 | 520 | 131 | 8 | EFO_0007629 | |
| Disease | response to homoharringtonine, cytotoxicity measurement | 2.55e-03 | 17 | 131 | 2 | EFO_0006952, EFO_0006996 | |
| Disease | Fetal Alcohol Syndrome | 2.55e-03 | 17 | 131 | 2 | C0015923 | |
| Disease | hypertension | 2.55e-03 | 307 | 131 | 6 | EFO_0000537 | |
| Disease | systolic blood pressure, alcohol drinking | 2.59e-03 | 128 | 131 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | Astigmatism | 2.66e-03 | 129 | 131 | 4 | HP_0000483 | |
| Disease | Calcium channel blocker use measurement | 2.67e-03 | 213 | 131 | 5 | EFO_0009930 | |
| Disease | Hematochezia, response to radiation | 3.53e-03 | 20 | 131 | 2 | GO_0009314, HP_0002573 | |
| Disease | bipolar I disorder | 3.66e-03 | 141 | 131 | 4 | EFO_0009963 | |
| Disease | biological sex | 3.70e-03 | 230 | 131 | 5 | PATO_0000047 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.85e-03 | 566 | 131 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | stroke | 3.95e-03 | 144 | 131 | 4 | EFO_0000712 | |
| Disease | Attention Deficit Disorder | 4.26e-03 | 22 | 131 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 4.26e-03 | 22 | 131 | 2 | C1321905 | |
| Disease | bipolar disorder | 4.32e-03 | 577 | 131 | 8 | MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRDSDYRSETSNSIP | 196 | Q9UPW8 | |
| EDPYTASLRSEIESD | 406 | Q6ZSZ5 | |
| SVEDAARLSQEDPDY | 246 | P04040 | |
| ESYTSRPSDSDVSLE | 61 | Q02641 | |
| YTSRPSLDSDVSLEE | 21 | P54284 | |
| SPIYEDDSSQEDILS | 2086 | Q68DQ2 | |
| RQTPASTLEQDATDY | 456 | Q6L9W6 | |
| LSRVLEDDPEAAYTT | 821 | P54756 | |
| SSLSEDYQDVIDTPV | 1356 | Q6RI45 | |
| NLDSDSTYRTPSVLN | 301 | Q9P1A6 | |
| SYPTAESQAEAERAL | 301 | Q53GS7 | |
| NLEDSDASVERSQYP | 126 | Q8WZ64 | |
| DASVERSQYPQSDDK | 131 | Q8WZ64 | |
| DSDSEAYPEDSERRS | 3866 | P20930 | |
| ALAADIPVRYESSDT | 221 | Q96M86 | |
| IPVRYESSDTDNAEV | 226 | Q96M86 | |
| SANSLYEPEGERQDS | 581 | Q15057 | |
| EKINAEPSESDTARY | 26 | Q9UPW5 | |
| LPSSQSRAEYDSEES | 2441 | Q9Y485 | |
| YETETARTPSSREEE | 391 | Q96BY7 | |
| SYTSRPSDSDVSLEE | 76 | Q08289 | |
| DSETQESRDSAYVEP | 556 | Q08289 | |
| FRETSNYSLPQDDID | 241 | P22894 | |
| QSDYTEDATDTKPDR | 1041 | Q9HBD1 | |
| REYSSELNAPSQESD | 216 | P49756 | |
| SERNDLESSYVPVSA | 206 | Q9P2N5 | |
| DNEYISSLPADADRT | 381 | Q6ZMN7 | |
| RQSEAADSSPSELKY | 136 | P04090 | |
| YDDVLTATSQPSDDR | 31 | Q8N684 | |
| ARETDYPAGEDLSES | 801 | O60271 | |
| YVLDSTDEARLPESA | 86 | Q969Q4 | |
| VADSYDPISTDASRR | 891 | P10071 | |
| ESSESSTYTAALPRE | 336 | Q8NFM7 | |
| SLSSPRASQSLVDYD | 616 | Q8NG48 | |
| VETDSEEAYASPAER | 116 | Q6DN12 | |
| EDEVLLVSSSRYPDQ | 31 | A0A024RBG1 | |
| ETRETCRASYDTSAP | 46 | Q9HCE5 | |
| DSSLSSYTVPLERDN | 416 | Q99700 | |
| TPVERNYTAVSSQDE | 3996 | Q2LD37 | |
| DISQAYRSAPERTED | 636 | Q8ND23 | |
| DKTSRSDSRAPVYDQ | 156 | Q05923 | |
| RIESYLNDHSEATPD | 496 | Q5T0W9 | |
| RTSEEPYTETELNSR | 566 | Q86YR7 | |
| YARSEDEDSLSPASA | 281 | Q9BZM3 | |
| RREPYDSVEESSESE | 1506 | Q9Y6V0 | |
| TDRDPQDTLTYSLAE | 3556 | Q9NYQ8 | |
| EDEVLLVSSSRYPDQ | 31 | Q9NZJ9 | |
| TYDEQVTSRAQEPLS | 136 | Q9HCR9 | |
| TETDVEERVYTPSNA | 226 | Q6L8Q7 | |
| TPSRTDDTAQVTSDY | 611 | Q14432 | |
| SYVPSDLTAEERQEL | 6 | Q15438 | |
| SGIRTSDDSSEEDPY | 1021 | Q9HD67 | |
| SPADINYEETLSTLR | 326 | O43896 | |
| DSRYSDIEPSTEGEV | 191 | P07942 | |
| RLELPQYTSSDSDVE | 681 | P07942 | |
| LERSTLQDSDEYSNP | 11 | O60711 | |
| SADSYDPISTDASRR | 851 | P10070 | |
| ETSYNTDRTDRTPAT | 456 | Q96N16 | |
| PEITASEYESTELSA | 16 | Q9H3V2 | |
| TSADLDRETVPEYNL | 411 | Q9UN70 | |
| QREPLSSETQYSVDT | 336 | Q99755 | |
| DALRPQDTEANATTY | 1301 | O00750 | |
| ESRVQAYEEPSVASS | 716 | Q99575 | |
| LSDVDSESSDISQPY | 411 | Q96EP1 | |
| ASDPYSRISQEDGDE | 2011 | Q9ULT8 | |
| SAYLKDDQRSTPDST | 201 | Q6ISB3 | |
| DDTTELSSAERYNPR | 516 | Q9Y2M5 | |
| VRQDAYTRSDSEPSK | 651 | Q5SW24 | |
| PSEEELQDSRVYVSS | 2206 | Q13936 | |
| QEDYLPSSTVERRSS | 71 | Q9ULE3 | |
| EESPVYSNSSVRNEL | 536 | Q03188 | |
| ESYPSVTLRTAEEES | 916 | Q9P2H0 | |
| ARSSPKSNDSDLQEY | 251 | Q53EP0 | |
| SRVLEDDPEATYTTS | 761 | P29317 | |
| EAVELERYTPSSTSA | 886 | Q8N3K9 | |
| LSRVLEDDPDAAYTT | 781 | P29322 | |
| DSRPSSAQLISDDSY | 2421 | Q12955 | |
| RALYDNTAESPQELS | 11 | O43281 | |
| EENPEESEYSVRASL | 91 | P22003 | |
| VPEYEARTEDNQSSE | 286 | Q9Y6X4 | |
| SASESIAEDLEEPSY | 191 | Q5VTH9 | |
| SDLRNDDSANDRVPY | 326 | Q8TC76 | |
| QISYASTAPELSDDR | 176 | Q14831 | |
| ETPEYRSRFTNEETV | 236 | Q9NUQ9 | |
| SITSDETTLEYQDAP | 1311 | Q8WYP5 | |
| SYTAQAERTPDLTEL | 406 | A6NE01 | |
| SDSYDSLSEAAERPQ | 141 | Q9ULX7 | |
| YESELTGSSERAEQP | 526 | Q9Y2W3 | |
| RTEESPLVDISSYQA | 2826 | Q8TDX9 | |
| SPESREELESEDSYN | 296 | Q8NCQ7 | |
| DLSYASRTTADPEVR | 1231 | Q9P2P1 | |
| SEVTAPVASDSSYRN | 481 | A8MW92 | |
| YPSDESVQDDRELQA | 496 | O15296 | |
| SYSDIEEIATPDSSA | 1236 | Q8NEY1 | |
| EEAEDLSAPSAAYTA | 486 | Q96JB3 | |
| SPAADNYDETLSTLR | 331 | Q9NQT8 | |
| SLALSRSQEPIYSEE | 2116 | Q5T011 | |
| YQDFIIDSREPDATT | 346 | Q96Q11 | |
| DPSASEIREELEQYT | 151 | O95602 | |
| DSLYRHDSDTPSDSL | 81 | Q6ZWK4 | |
| GYEVAPRSDSEESDS | 626 | P51531 | |
| YIDLSSDSEDVVSPN | 91 | Q9H4L7 | |
| TAVSSDDEYPTRNSI | 1051 | Q14C87 | |
| AVSRENPVASDSYEA | 476 | A6NFQ2 | |
| EVLQDSLDRSYSTPS | 991 | P0DPF2 | |
| EVLQDSLDRSYSTPS | 3431 | P0DPF2 | |
| YTDSSDDEVSPREKQ | 81 | O43865 | |
| SASQIPSEREEAQYD | 476 | O60331 | |
| GEDYTDIPLSDSNRD | 166 | Q9Y252 | |
| SPSSRTALAEAELEY | 246 | Q9NSE4 | |
| DAYEGASESSLERPE | 206 | Q9BZV3 | |
| LQPEESTETLDSSYV | 266 | Q8N0Z3 | |
| QYRDSSSEDESSRPT | 106 | Q15047 | |
| EQSLTEYSDLEEAPS | 31 | Q499Z3 | |
| RRNENPDDSTYVDIT | 211 | P17787 | |
| SGERLSSIPEASEYD | 521 | Q6ZVT6 | |
| LEEDSSDYSIPSRTS | 891 | Q96JQ2 | |
| AYPSSEDLDSVSRSE | 631 | Q8N2E2 | |
| SETEASRIANEYPED | 616 | Q15111 | |
| IDLVSSDDEEPSTSY | 46 | Q9Y4E5 | |
| TQDDVDLYTDSEPRA | 331 | Q9UM82 | |
| SRNTLDSEVPAAYQT | 1091 | Q7Z2Z1 | |
| ARLDSDVSPLETESY | 176 | Q96C74 | |
| PERLKASENSESEYS | 306 | Q8IXW5 | |
| KIERANSYSAEEPSA | 1656 | Q9HCF6 | |
| DEYENSLSRSAVLQP | 6 | Q9P253 | |
| DLELPSTENEYVSTS | 311 | O75554 | |
| EYSEISPETAQLRAS | 306 | Q3KQV9 | |
| SSSSTLAYSPRDEED | 61 | Q6Q0C0 | |
| QEARDTPDQEGSTYE | 361 | A6NKC9 | |
| AERDSSTPYQEIAAV | 156 | O95359 | |
| SSPTEELDYRNSYEI | 2511 | O95359 | |
| KSDTSLYENDTDEPR | 286 | Q5VVX9 | |
| SRQQEELPIYSSDFE | 1196 | Q9BYW2 | |
| EETSSSASDQPYQRE | 606 | O43296 | |
| PDTSQRQVDSTLAAY | 526 | Q8TCN5 | |
| NSEAYDELVPASLTT | 141 | Q9NPG3 | |
| SSEEEYSRNELDSPH | 306 | Q8TBZ6 | |
| ASSIEYSTRPRDTEE | 81 | P57768 | |
| LENSAPESASRTSRY | 1921 | Q5VUA4 | |
| PERASESSSEEKDDY | 1776 | P18583 | |
| INLSATDYPTRTNEE | 326 | Q9H1B5 | |
| ARDYLSSATDNPTAS | 836 | B0I1T2 |